We are live on
!
Find out more
Acadian Asset Management Portfolio holdings
AUM
$70.5B
1-Year Est. Return
36%
This Fund
S&P 500
This Quarter
Est. Return
+7.95%
1 Year Est. Return
+36%
3 Year Est. Return
+137.96%
5 Year Est. Return
+215.76%
10 Year Est. Return
+864.44%
AUM
$24.3B
AUM Growth
+$1.52B
(+6.7%)
Cap. Flow
+$416M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
19.48%
Holding
1,977
New
232
Increased
535
Reduced
722
Closed
249
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$298M |
| 2 |
Spotify
SPOT
|
+$249M |
| 3 |
NVIDIA
NVDA
|
+$230M |
| 4 |
Cardinal Health
CAH
|
+$129M |
| 5 |
Vipshop
VIPS
|
+$127M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amdocs
DOX
|
+$125M |
| 2 |
Crane NXT
CXT
|
+$114M |
| 3 |
Deutsche Bank
DB
|
+$96M |
| 4 |
Qiagen
QGEN
|
+$92.3M |
| 5 |
Arista Networks
ANET
|
+$83.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.06% |
| 2 | Healthcare | 13.93% |
| 3 | Consumer Staples | 11.94% |
| 4 | Consumer Discretionary | 10.19% |
| 5 | Communication Services | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONTF
476
DELISTED
ON24
ONTF
| $4.72M | 0.02% |
581,186
-20,825
| -3% | -$173K |
|
477
Tenet Healthcare
THC
$20.9B
| $4.71M | 0.02% |
57,920
-178,974
| -76% | -$12.7M |
|
478
Brady Corp
BRC
$4.54B
| $4.7M | 0.02% |
98,978
+71,738
| +263% | +$3.61M |
|
479
Capital City Bank Group
CCBG
$881M
| $4.66M | 0.02% |
152,106
-5,044
| -3% | -$152K |
|
|
TRUE
480
DELISTED
TrueCar
TRUE
| $4.65M | 0.02% |
2,060,061
+67,687
| +3% | +$161K |
|
481
Teekay
TK
$973M
| $4.65M | 0.02% |
770,406
-71,528
| -8% | -$418K |
|
482
Upland Software
UPLD
$14.5M
| $4.63M | 0.02% |
128,790
+64,771
| +101% | +$2.23M |
|
483
Extreme Networks
EXTR
$3.09B
| $4.6M | 0.02% |
176,607
+101,207
| +134% | +$2M |
|
484
South Plains Financial
SPFI
$838M
| $4.58M | 0.02% |
203,632
-6,398
| -3% | -$139K |
|
485
iQIYI
IQ
$1.31B
| $4.58M | 0.02% |
860,220
-3,445,713
| -80% | -$19.4M |
|
486
CytomX Therapeutics
CTMX
$750M
| $4.56M | 0.02% |
2,653,576
| – | – |
|
487
SunCoke Energy
SXC
$799M
| $4.48M | 0.02% |
569,695
-213,477
| -27% | -$1.68M |
|
488
Accuray
ARAY
$34.9M
| $4.46M | 0.02% |
1,153,120
-64,054
| -5% | -$222K |
|
|
YMAB
489
DELISTED
Y-mAbs Therapeutics
YMAB
| $4.44M | 0.02% |
654,088
+254,506
| +64% | +$1.91M |
|
490
LivePerson
LPSN
$31.2M
| $4.42M | 0.02% |
+65,244
| New | +$4.23M |
|
|
EGRX
491
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $4.36M | 0.02% |
224,576
+9,145
| +4% | +$217K |
|
|
ARC
492
DELISTED
ARC Document Solutions, Inc.
ARC
| $4.35M | 0.02% |
1,343,749
-16,886
| -1% | -$50.6K |
|
493
Fate Therapeutics
FATE
$322M
| $4.34M | 0.02% |
+912,917
| New | +$5.04M |
|
494
First Financial Corp
THFF
$962M
| $4.33M | 0.02% |
133,410
-49,642
| -27% | -$1.69M |
|
495
Samsara
IOT
$23.2B
| $4.3M | 0.02% |
155,506
+152,641
| +5,328% | +$3.38M |
|
|
WCC
496
WESCO International
WCC
$17.9B
| $4.26M | 0.02% |
23,818
-176,031
| -88% | -$25.7M |
|
|
CGAU
497
Centerra Gold
CGAU
$4.17B
| $4.25M | 0.02% |
709,549
-1,794,157
| -72% | -$11.4M |
|
498
Fiverr
FVRR
$327M
| $4.25M | 0.02% |
163,891
-150,039
| -48% | -$4.52M |
|
499
Core Molding Technologies
CMT
$223M
| $4.25M | 0.02% |
186,854
+85,083
| +84% | +$1.65M |
|
500
PayPal
PYPL
$50.5B
| $4.24M | 0.02% |
63,620
-11,885
| -16% | -$810K |
|
Similar funds
Acadian Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Acadian Asset Management held 1,977 positions worth $24.3B, up 6.7% from $22.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Acadian Asset Management's Q2 2023 filing shows 232 new, 535 increased, 722 reduced and 249 closed positions. Its largest new stake was Indivior Pharmaceuticals: 2,328,706 shares worth $54M. The largest sale was Amdocs, an estimated $125M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Staples.
- Acadian Asset Management's largest Q2 2023 buy was Indivior Pharmaceuticals: 2,328,706 shares worth $54M.
- Acadian Asset Management added most to Alphabet (Google) Class A in Q2 2023, an estimated $298M increase.
- Acadian Asset Management's biggest Q2 2023 reduction was Crane NXT, cutting an estimated $114M.
- Acadian Asset Management fully exited Amdocs in Q2 2023, selling an estimated $125M.
- Acadian Asset Management's ten largest holdings make up 19% of its $24.3B portfolio in Q2 2023.
- Acadian Asset Management opened 232 new positions and closed 249 in Q2 2023.
- Acadian Asset Management's portfolio value rose 6.7% quarter-over-quarter to $24.3B.
Based on Acadian Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.